Briefs
-
Annex 1-6 : SAIC mid-term evaluation
Published date
2016
A critical conclusion from this analysis is that patent strategies in the pharmaceutical industry can reduce access to drugs.
Despite the decline in the discovery of new chemical entities for pharmaceutical use, there is a significant proliferation of patents on products and processes that cover minor, incremental innovations.